Jitsubo Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Jitsubo Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12379
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Jitsubo Co Ltd (Jitsubo), a subsidiary of Sosei Group Corp, is a biotechnology company that develops, manufactures and commercializes peptide therapeutics. The company’s molecular hiving technology modifies the polysaccharide and sugar chain peptide sequence. Its Molecular Hiving technology has two part technologies such as thermomorphic system and hydrophobic tag. Jitsubo provide peptide synthesis to modify amino acid sequence for the creation of physical, chemical and pharmacological properties. The company also provides technology for collaborative research. It also partners with other biotechnology companies for product optimization and process optimization. Jitsubo is headquartered in Yokohama, Japan.

Jitsubo Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jitsubo Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Jitsubo Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Jitsubo Enters into Agreement with Heptares Therapeutics 11
Equity Offering 12
Jitsubo to Raise USD1.7 Million in Private Placement 12
Acquisition 13
Sosei Acquires Stake in Jitsubo for USDUSD1.8 Million 13
Jitsubo Co Ltd – Key Competitors 14
Jitsubo Co Ltd – Key Employees 15
Jitsubo Co Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jitsubo Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jitsubo Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Jitsubo Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Jitsubo Enters into Agreement with Heptares Therapeutics 11
Jitsubo to Raise USD1.7 Million in Private Placement 12
Sosei Acquires Stake in Jitsubo for USDUSD1.8 Million 13
Jitsubo Co Ltd, Key Competitors 14
Jitsubo Co Ltd, Key Employees 15

List of Figures
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jitsubo Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Jitsubo Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Jitsubo Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aeon Co., Ltd.:企業の戦略・SWOT・財務情報
    Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Freudenberg & Co KG:企業の戦略的SWOT分析
    Freudenberg & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Allergan Plc (AGN):企業の財務・戦略的SWOT分析
    Allergan Plc (AGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • AlloSource:企業の戦略的SWOT分析
    AlloSource - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • China State Construction International Holdings Limited:戦略・SWOT・企業財務分析
    China State Construction International Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary China State Construction International Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • LycoRed Ltd:戦略・SWOT・企業財務分析
    LycoRed Ltd - Strategy, SWOT and Corporate Finance Report Summary LycoRed Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • PCL Constructors Inc:企業の戦略的SWOT分析
    PCL Constructors Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Nordic Bioscience AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Nordic Bioscience AS (Nordic Bioscience), formerly Danish Biotech Co is a preclinical and clinical drug development company that offers serological biochemical solutions. The company offers diagnostic products, laboratory kits and biochemical assays. It provides degradation biomarkers, forma …
  • Fabasoft Ag
    Fabasoft Ag - Strategy, SWOT and Corporate Finance Report Summary Fabasoft Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Berger Paints India Ltd (BERGEPAINT):企業の財務・戦略的SWOT分析
    Berger Paints India Ltd (BERGEPAINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bioasis Technologies Inc (BTI):企業の財務・戦略的SWOT分析
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …
  • Population Genetics Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary Population Genetics Technologies Ltd (Population Genetics) is a biotechnology company that offers diagnostic test solutions. The company provides products such as diagnostic test kits, HIV diagnostic test systems, and HCV diagnostic test systems. Its diagnostic test kits provide reagent assa …
  • Softship AG:企業の戦略的SWOT分析
    Softship AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Technology Nexus AB:企業の戦略的SWOT分析
    Technology Nexus AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Australian Postal Corporation:企業の戦略・SWOT・財務情報
    Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report Summary Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Viztek LLC-医療機器分野:企業M&A・提携分析
    Summary Viztek LLC (Viztek), a subsidiary of Konica Minolta Medical Imaging USA Inc is a healthcare technology company that offers digital software and hardware imaging solutions. The company offers products such as opal-ORTHO, Opal-wRIS, CR, opal-CR II, opal-CHIRO, opal-RAD, opal-CLOUD, Viztek DR, …
  • Natcore Technology Inc (NXT):企業の財務・戦略的SWOT分析
    Summary Natcore Technology Inc (Natcore) is a solar research and development company that provides products for semiconductor and fiber optic applications. The company’s products include solar cell structures and black silicon cells. It uses liquid phase deposition technology for controlling deposit …
  • Planung Transport Verkehr AG:企業の戦略的SWOT分析
    Planung Transport Verkehr AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Cordis Corp:医療機器:M&Aディール及び事業提携情報
    Summary Cordis Corporation (Cordis), a subsidiary of a Cardinal Health Inc., develops and manufactures interventional vascular products in the area of cardiology as well as for use in endovascular surgery. The company’s cardiology portfolio comprises sheaths, diagnostic guidewires, diagnostic cathet …
  • Diebold Nixdorf, Incorporated:戦略・SWOT・企業財務分析
    Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆